Literature DB >> 10913167

Aldose reductase-deficient mice develop nephrogenic diabetes insipidus.

H T Ho1, S K Chung, J W Law, B C Ko, S C Tam, H L Brooks, M A Knepper, S S Chung.   

Abstract

Aldose reductase (ALR2) is thought to be involved in the pathogenesis of various diseases associated with diabetes mellitus, such as cataract, retinopathy, neuropathy, and nephropathy. However, its physiological functions are not well understood. We developed mice deficient in this enzyme and found that they had no apparent developmental or reproductive abnormality except that they drank and urinated significantly more than their wild-type littermates. These ALR2-deficient mice exhibited a partially defective urine-concentrating ability, having a phenotype resembling that of nephrogenic diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913167      PMCID: PMC86061          DOI: 10.1128/MCB.20.16.5840-5846.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  [The mechanism of the transformation of glucose in fructose in the seminal vesicles].

Authors:  H G HERS
Journal:  Biochim Biophys Acta       Date:  1956-10

Review 2.  Congenital nephrogenic diabetes insipidus.

Authors:  D G Bichet; A Oksche; W Rosenthal
Journal:  J Am Soc Nephrol       Date:  1997-12       Impact factor: 10.121

3.  Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.

Authors:  T F Ng; F K Lee; Z T Song; N A Calcutt; A Y Lee; S S Chung; S K Chung; D T Ng; L W Lee
Journal:  Diabetes       Date:  1998-06       Impact factor: 9.461

4.  Long-term regulation of four renal aquaporins in rats.

Authors:  J Terris; C A Ecelbarger; S Nielsen; M A Knepper
Journal:  Am J Physiol       Date:  1996-08

5.  Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate.

Authors:  D L Vander Jagt; N S Kolb; T J Vander Jagt; J Chino; F J Martinez; L A Hunsaker; R E Royer
Journal:  Biochim Biophys Acta       Date:  1995-06-12

6.  Histochemistry and ultrastructure of the interstitium of the renal papilla in rats with hereditary diabetes insipidus (Brattleboro strain).

Authors:  W G Mcauliffe
Journal:  Am J Anat       Date:  1980-01

7.  Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus.

Authors:  S Homma; S M Gapstur; A Coffey; H Valtin; T P Dousa
Journal:  Am J Physiol       Date:  1991-08

8.  Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.

Authors:  P M Deen; M A Verdijk; N V Knoers; B Wieringa; L A Monnens; C H van Os; B A van Oost
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

9.  Renal deficiency associated with diabetes insipidus in the SWR/J mouse.

Authors:  C L Kutscher; M Miller; N L Schmalbach
Journal:  Physiol Behav       Date:  1975-06

10.  Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat.

Authors:  S R DiGiovanni; S Nielsen; E I Christensen; M A Knepper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more
  42 in total

1.  EHD4 is a novel regulator of urinary water homeostasis.

Authors:  Shamma S Rahman; Alexandra E J Moffitt; Andrew J Trease; Kirk W Foster; Matthew D Storck; Hamid Band; Erika I Boesen
Journal:  FASEB J       Date:  2017-08-04       Impact factor: 5.191

2.  Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice.

Authors:  Srinivasan Vedantham; HyeLim Noh; Radha Ananthakrishnan; Ni Son; Kellie Hallam; Yunying Hu; Shuiquing Yu; Xiaoping Shen; Rosa Rosario; Yan Lu; Thyyar Ravindranath; Konstantinos Drosatos; Lesley Ann Huggins; Ann Marie Schmidt; Ira J Goldberg; Ravichandran Ramasamy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

Review 3.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

4.  Aldose reductase inhibition enhances lens regeneration in mice.

Authors:  Leonid M Zukin; Michelle G Pedler; Kevin Chyung; Sarah Seiwald; Patricia Lenhart; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2019-04-23       Impact factor: 5.192

5.  Functional studies of aldo-keto reductases in Saccharomyces cerevisiae.

Authors:  Qing Chang; Terry A Griest; Theresa M Harter; J Mark Petrash
Journal:  Biochim Biophys Acta       Date:  2006-10-21

6.  Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity.

Authors:  Zhongjie Fu; Shen Nian; Suk-Yee Li; David Wong; Sookja K Chung; Amy C Y Lo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-29       Impact factor: 3.117

7.  Influence of aldose reductase on epithelial-to-mesenchymal transition signaling in lens epithelial cells.

Authors:  Kun-Che Chang; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2017-01-27       Impact factor: 5.192

8.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

9.  Disruption of aldo-keto reductase genes leads to elevated markers of oxidative stress and inositol auxotrophy in Saccharomyces cerevisiae.

Authors:  Qing Chang; J Mark Petrash
Journal:  Biochim Biophys Acta       Date:  2007-09-05

10.  Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.

Authors:  Sarah Lambert-Langlais; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Fanny Volat; Michèle Manin; François Coudoré; Pierre Val; Isabelle Sahut-Barnola; Bruno Ragazzon; Estelle Louiset; Catherine Delarue; Hervé Lefebvre; Yoshihiro Urade; Antoine Martinez
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.